RAPPAPORT ANDREW 4
4 · Olema Pharmaceuticals, Inc. · Filed Nov 23, 2020
Insider Transaction Report
Form 4
RAPPAPORT ANDREW
Director
Transactions
- Conversion
Common Stock
2020-11-23+318,723→ 351,181 total(indirect: See Footnote) - Conversion
Common Stock
2020-11-23+129,833→ 481,014 total(indirect: See Footnote) - Conversion
Series A-1 Convertible Preferred Stock
2020-11-23−129,833→ 0 total(indirect: See Footnote)→ Common Stock (129,833 underlying) - Conversion
Series A Convertible Preferred Stock
2020-11-23−318,723→ 0 total(indirect: See Footnote)→ Common Stock (318,723 underlying)
Footnotes (2)
- [F1]The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock.
- [F2]The shares are held by SPW Investments LLC ("SPWI"). Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI.